(Total Views: 189)
Posted On: 04/22/2017 2:34:21 PM
Post# of 72446
Yesterday's price action was no different than the previous ASCO, Rodman & Renshaw and Biotech Showcase since I invested seven years ago. They were hyped by some before the presentation then sold-off after. Each time the same people questioned Leo's credibility after the presentation.
If that was the case, why did the stock rebounded each time? It was because CTIX continued to produce solid clinical data. Guess what? The company expects to produce four more Phase 2 top-line data this year.
Biotechs can be extremely volatile, especially a pre-revenue one trading on the OTC. There are a lot of manipulations going on, as evident by Mako/AF's constant hit pieces and Rosen's dismissed with prejudice lawsuit.Yesterday was a gut check of whether you are right for this kind of investment.
Bunny/Monolith/A17 are not answering my posts over there. I guess it's hard to argue with facts or logic, so they pray on the weak instead.
P.S. Hi LR, you are welcome to share your wisdom here.
If that was the case, why did the stock rebounded each time? It was because CTIX continued to produce solid clinical data. Guess what? The company expects to produce four more Phase 2 top-line data this year.
Biotechs can be extremely volatile, especially a pre-revenue one trading on the OTC. There are a lot of manipulations going on, as evident by Mako/AF's constant hit pieces and Rosen's dismissed with prejudice lawsuit.Yesterday was a gut check of whether you are right for this kind of investment.
Bunny/Monolith/A17 are not answering my posts over there. I guess it's hard to argue with facts or logic, so they pray on the weak instead.
P.S. Hi LR, you are welcome to share your wisdom here.
(0)
(0)
